ERFURT and BERLIN, Germany, April 7th, 2021, AMP Alternative Medical Products Inc. (Frankfurt: C4TA, ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis to German pharmacies, announces the appointment of Mr. Robert Schenk as National Sales Director and the launch of AMP’s nationwide Marketing Sales Campaign for branded medical cannabis products.
Mr. Schenk, who will oversee the development and execution of AMP’s sales and marketing strategies and lead our nationwide sales team, officially joins AMP today. Mr. Schenk brings over 20 years of experience in the pharmaceutical industry to AMP and was most recently, Regional Manager of Canopy Growth Germany GmbH, a subsidiary of Canopy Growth Corporation (Nasdaq: CGC), where he established, built and lead Canopy’s nationwide sales team in Germany.
AMP also launched its marketing sales campaign for AMP’s line of branded medical cannabis products, which includes cannabis flower products: Aphria Strong 9, Bedrocan and Bediol Cannabis Floss, as well as extracts: Little Green Pharma Classic 20:5 and Classic 10:10. AMP will be launching its cannabis flower product AMP Classic 18/1 Primary in May 2021 supplied by Schroll Medical and additional AMP branded flower and extract products from Canada as well as Australia during the second half of the year. German doctors and pharmacists can find further information about AMP’s medical cannabis products at www.amp-eu.com/doccheck-login/.
AMP’s nationwide sales team includes highly capable and accomplished pharmaceutical sales representatives in Stade, Cologne, Nordhausen and Speyer who are selling Aphria and AMP’s catalogue of medical cannabis products to over 13,000 pharmacies under AMP’s co-promotion agreement with CC Pharma, a national pharmaceutical distributor and a wholly-owned subsidiary of Aphria Inc. (Nasdaq: APHA).